Research and development of antibacterial agents
- 1 October 1998
- journal article
- review article
- Published by Elsevier in Current Opinion in Microbiology
- Vol. 1 (5) , 495-501
- https://doi.org/10.1016/s1369-5274(98)80080-5
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- The therapeutic potential of cationic peptidesExpert Opinion on Investigational Drugs, 1998
- Cationic peptides: a new source of antibioticsTrends in Biotechnology, 1998
- New strategies for antibacterial drug designTrends in Microbiology, 1997
- Emergent antibiotic resistance: health risks and economic impactFEMS Immunology & Medical Microbiology, 1997
- Novel targets for antibiotics - an updateExpert Opinion on Investigational Drugs, 1997
- Beyond vancomycin: new therapies to meet the challenge of glycopeptide resistanceTrends in Microbiology, 1997
- Conditionally Lethal Escherichia coli Murein Mutants Contain Point Defects That Map to Regions Conserved among Murein and Folyl Poly-γ-glutamate Ligases: Identification of a Ligase SuperfamilyBiochemistry, 1997
- Oxazolidinone antibacterial agents: development of the clinical candidates eperezolid and linezolidExpert Opinion on Investigational Drugs, 1997
- The renewed challenge of antibacterial chemotherapy†Chemical Communications, 1997
- Streptogramin analoguesExpert Opinion on Investigational Drugs, 1994